TownSquare Capital’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,447
Closed -$627K 665
2025
Q1
$627K Buy
19,447
+3,309
+21% +$123K 0.01% 1030
2024
Q4
$493K Sell
16,138
-789
-5% -$25.4K 0.01% 1029
2024
Q3
$475K Sell
16,927
-1,399
-8% -$34.5K 0.01% 989
2024
Q2
$417K Buy
18,326
+3,758
+26% +$86.7K 0.01% 951
2024
Q1
$443K Sell
14,568
-4,759
-25% -$159K 0.01% 886
2023
Q4
$690K Sell
19,327
-42
-0.2% -$1.56K 0.01% 692
2023
Q3
$848K Sell
19,369
-7,875
-29% -$384K 0.02% 605
2023
Q2
$1.34M Buy
27,244
+132
+0.5% +$6.08K 0.02% 479
2023
Q1
$1.12M Buy
27,112
+7,705
+40% +$320K 0.02% 452
2022
Q4
$861K Buy
19,407
+8,822
+83% +$368K 0.02% 490
2022
Q3
$414K Sell
10,585
-164
-2% -$7.5K 0.01% 519
2022
Q2
$439K Sell
10,749
-3,854
-26% -$183K 0.01% 491
2022
Q1
$958K Sell
14,603
-293
-2% -$19K 0.02% 356
2021
Q4
$1.03M Buy
14,896
+475
+3% +$34.5K 0.03% 356
2021
Q3
$1M Buy
14,421
+4,214
+41% +$324K 0.03% 343
2021
Q2
$814K Buy
10,207
+148
+1% +$10.8K 0.03% 347
2021
Q1
$659K Buy
+10,059
New +$619K 0.03% 359

Other funds holding ATRC

TownSquare Capital's ATRC Position: Q2 2025 in Review

TownSquare Capital sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 19,447 shares — an estimated $627K sold.

TownSquare Capital first reported a position in ATRC in Q1 2021 and held it in 17 quarters. The position peaked at $1.34M in Q2 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • TownSquare Capital reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 19,447 AtriCure shares in Q2 2025, an estimated $627K.
  • TownSquare Capital first reported a position in AtriCure in Q1 2021 and held it in 17 quarters.
  • TownSquare Capital's AtriCure position peaked at $1.34M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.